Singaporean-based startup, Smarter Health, has received $5.15 million SGD (about $3.8 million USD) in their Series A round by East Ventures. ... Jan 04
The European Commission has granted marketing authorization for Supemtek®, a quadrivalent (four-strain) recombinant influenza vaccine, for the prevention of influenza in adults aged 18 ... Nov 20
CHMP has adopted a positive opinion for Supemtek for active immunization for the prevention of influenza in adults... Sep 23
-Advertisements-